NCT07048301

Brief Summary

Background: Infectious diseases remain significant public health concerns due to several factors such as climate and environmental changes and natural disasters. Mobile health applications (mHealth apps) can be an appropriate way for fostering community participation, disseminating knowledge, and promoting behavior change toward infectious disease prevention. This study aims to describe a protocol for a pilot randomized controlled study to evaluate the impact of the Omaha System-Based mHealth app (BUHOS) on improving knowledge, attitude, and behaviors (KAB) regarding infectious disease prevention in an earthquake-affected region of Türkiye. Methods: This study is a two-armed, parallel-group, randomized controlled trial design. A total of 112 eligible participants will be recruited from two separate container cities of an earthquake-affected region. These participants will be randomly allocated to either an intervention group or a control group. BUHOS will be designed based on the Omaha System, a widely recognized standardized taxonomy for the assessment, planning, and evaluation of healthcare services. BUHOS will be a two-week nursing intervention that includes monitoring KAB, employing Education, Guidance and Counseling (education videos), and Surveillance (reminder messages), and assessing the outcomes. Outcome variables will include the Problem Rating Scale for Outcomes, Community Communicable Diseases Knowledge Survey, Communicable Diseases Risk Awareness and Protection Scale and System Usability Scale. Outcome variables will be assessed on the 15th and 30th day after intervention. Hypotheses: H1: Among the Omaha System Problems, the Communicable/ Infectious Condition Problem Knowledge score will be higher on the 15th and 30th days compared to the control group. H2: Infectious diseases risk awareness and prevention score will be higher on the 15th and 30th days compared to the control group. H3: Communicable/ Infectious Condition Status Behaviour Parameter score will be higher on the 15th and 30th days compared to the control group H4: The knowledge and behaviour of the communicable/ infectious status and the awareness and prevention of the risk of infectious diseases of the experimental group will be higher than before the intervention on the 15th and 30th days.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Sep 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Sep 2025Jun 2026

First Submitted

Initial submission to the registry

June 23, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

July 2, 2025

Status Verified

June 1, 2025

Enrollment Period

3 months

First QC Date

June 23, 2025

Last Update Submit

June 24, 2025

Conditions

Keywords

Omaha SystemMobile health app

Outcome Measures

Primary Outcomes (4)

  • Omaha System- Problem Rating Scale for Outcomes Knowledge parameter

    15th and 30th day after intervention

  • Omaha System- Problem Rating Scale for Outcomes Behavior parameter

    15th and 30th day after intervention

  • Communicable Diseases Risk Awareness and Protection Scale (CDRAPS)

    15th and 30th day after intervention

  • Community Communicable Diseases Knowledge Survey

    15th and 30th day after intervention

Secondary Outcomes (1)

  • System Usability Scale (SUS)

    30th day after intervention

Study Arms (2)

BUHOS app

EXPERIMENTAL

BUHOS app

Other: BUHOS app

Control Group

ACTIVE COMPARATOR

Control Group

Other: Control Group

Interventions

In this study, the BUHOS app initiative will be implemented among participants in the intervention group. BUHOS will be a two-weeks nursing intervention that includes monitoring KAB, employing Education, Guidance and Counseling (education videos), and Surveillance (reminder messages), and assessing the outcomes.

BUHOS app

No intervention will be made to the patients in the control group, and the training videos prepared after the study is completed will be shared.

Control Group

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • being aged between 18 and 64 years,
  • living in two container cities,
  • having a knowledge score of 'very low (1)' and 'low (2)' on the Omaha System Problem Rating Scale for Outcome for Communicable/ Infectious Problem Knowledge Parameter,
  • being literate,
  • owning a smartphone.

You may not qualify if:

  • having impaired vision or hearing,
  • having a mental illness,
  • not owning a smartphone,
  • being pregnant or postpartum,
  • being participants in another scientific study,
  • refusing to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Secginli S, Altiner Yas M, Torun G, Ilhan N, Dogru Bolat S. Developing an Omaha System-based health application to improve knowledge, attitude, and behaviors regarding infectious disease prevention in the community: a study protocol for a randomized controlled trial. BMC Public Health. 2025 Nov 27;25(1):4170. doi: 10.1186/s12889-025-25587-8.

MeSH Terms

Conditions

Communicable DiseasesBehavior

Interventions

Control Groups

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Nesrin İlhan, Assoc. Prof.

    Istanbul Medeniyet University

    PRINCIPAL INVESTIGATOR
  • Selda Seçginli

    Atlas University

    STUDY DIRECTOR
  • Seda Doğru Bolat, Msc.

    Hatay State Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Merve Altıner Yaş, Assistant Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

June 23, 2025

First Posted

July 2, 2025

Study Start

September 1, 2025

Primary Completion

December 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

July 2, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share